SHSong Hon Hwang

Song Hon Hwang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Song Hon Hwang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk‐Stratified Bilateral Tonsillectomy for Unilateral HPV ‐Associated Tonsillar SCC : Oncologic and Functional Outcomes From a Single Institution

    by Tereza Vitkovska, Crystal Z. Zhou, Ishna Pandey, Maxwell L. Weng, Lauran K. Evans, Song Hon Hwang, Christian Wooten, Dipti Sajed, Maie A. St. John

    Objective: To characterize synchronous and metachronous contralateral second primary malignancy (SPM) rates across preoperatively defined risk strata in patients with HPV‐positive tonsillar squamous cell carcinoma (TSCC) undergoing unilateral versus bilateral tonsillectomy and to evaluate associated postoperative morbidity and functional outcomes. Methods: All patients with HPV‐positive TSCC who underwent surgery between 2000 and 2023 were retrospectively reviewed. Fisher's exact test, Kaplan–Meier analysis, and log‐rank tests were used to compare morbidity and survival, and multivariable regression models were employed to control for confounders, including patient demographics, substance use, tumor staging, and adjuvant therapy. Results: From 163 patients, 123 (75.5%) underwent unilateral tonsillectomy, 30 (18.4%) low‐risk bilateral tonsillectomy, and 10 (6.1%) high‐risk bilateral tonsillectomy. Across all patients undergoing bilateral tonsillectomy, synchronous tonsillar SPMs were identified in 10.0%, with rates of 6.7% in the low‐risk bilateral group and 20.0% in the high‐risk bilateral group. Of the 123 patients who underwent unilateral tonsillectomy, 0.8% developed a metachronous contralateral TSCC at 181.6 months. Among low‐risk bilateral patients undergoing prophylactic contralateral tonsillectomy, the NNT for identification of one occult synchronous SPM was 14 (95% CI: 5–50). Bilateral tonsillectomy did not significantly alter discharge diet, postoperative length of stay, hemorrhage rates, return to the operating room, or 30‐day emergency department visits. Disease‐free survival did not differ significantly across risk‐stratified groups. Conclusion: Contralateral second primary TSCC clustered disproportionately among high‐risk patients. Bilateral tonsillectomy was not associated with significantly increased postoperative morbidity. These findings support a selective, risk‐stratified approach to bilateral tonsillectomy in HPV‐associated TSCC, balancing the potential benefit of occult contralateral disease detection against procedure‐related morbidity through shared decision‐making. Level of Evidence: III.

  • Open Access

    Impact of Co‐Morbid Immunocompromise in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma

    by Maxwell L. Weng, Tereza Vitkovska, Song Hon Hwang, Lauran K. Evans, Hong‐Ho Yang, Christopher Dann, Dipti Sajed, Maie A. St. John

    Objectives: To characterize the survival and morbidity associated with immunocompromised status in patients with surgically resected Human Papillomavirus positive oropharyngeal squamous cell carcinoma (HPV + OPSCC). Methods: We reviewed patients with surgically resected HPV + OPSCC at a tertiary institution between 2000 and 2023. The survival and morbidity associated with an immunocompromised status were assessed with multivariable Cox proportional hazards models controlling for patient, tumor, and treatment characteristics. Results: Among 278 patients with HPV+ OPSCC that met inclusion criteria, 14 patients were immunocompromised. Causes of immunocompromise: 4, leukemia or lymphoma; 3, organ transplantation; 3, medically immunosuppressed; 2, HIV; 2, myelodysplastic syndrome and pancytopenia. Adjusting for covariates, the immunocompromised patient group had significantly worse overall survival (64.3% vs. 91.7%; HR 4.12, 95% CI: 1.14–14.90, p < 0.005) compared to the non‐compromised group. The immunocompromised patient group did not have a significantly different postoperative length of stay (3.96 vs. 3.5 days; aβ 0.66, 95% CI: −1.30 to 2.64). Conclusions: In this small, heterogeneous cohort of surgically resected HPV + OPSCC, immunocompromised status was associated with significantly worse overall survival; however, these exploratory findings should be interpreted cautiously. Level of Evidence: 3.

  • Open Access

    Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients

    by Song Hon Hwang, Maie St. John

    Cutaneous squamous cell carcinoma (cSCC) is the second most common skin malignancy in the world, representing approximately 20% of all skin cancers. Immunosuppression is a well-established risk factor, contributing not only to the development of new cSCC lesions but also to more aggressive disease and increased mortality. Despite the National Comprehensive Cancer Network (NCCN) and the American Joint Committee on Cancer (AJCC) 8th edition updates recognizing immunosuppression as a risk factor for cSCC, standardized management protocols for these high-risk patients remain limited. As a result, treatment of this already high-risk group remains a significant challenge and highlights the need for dedicated research and attention to improve outcomes in this patient population. This review explores the current knowledge regarding cSCC in IS patients, outlines key gaps in the knowledge, and highlights recent clinical trials to further guide the evaluation and management of these patients.


  • What Is the Effectiveness of Tocopherol and Pentoxifylline in the Treatment of Osteoradionecrosis of the Mandible?

    by Song Hon Hwang, Matthew E. Lin, Maie St. John

    This article reviews the current literature on the use of pentoxifylline and tocopherol for the medical management of osteoradionecrosis of the mandible after head and neck radiotherapy.

  • What Is the Role of Dental Extractions in the Peri‐Operative/Peri‐Treatment Period for Patients With Head and Neck Cancer?

    by Matthew E. Lin, Song Hon Hwang, Desiree Delavary, Maie St. John

    Dental extractions play an important role in patients with head and neck cancer who undergo surgery and radiation therapy. This article reviews the current literature on the role of dental evaluation prior to surgery or radiation therapy.